Le Lézard
Classified in: Health
Subjects: CHI, SVY, BLK, DEI

Black Children with Atopic Dermatitis Less Likely to be Evaluated by Allergists than Their White Peers


Research being presented at the 2023 AAAAI Annual Meeting examines racial disparities in the atopic march, which can help predict the progression of allergic diseases early in life.

MILWAUKEE, Feb. 7, 2023 /PRNewswire-PRWeb/ -- Despite research showing that black children are more likely to develop asthma, researchers found that black children diagnosed with atopic dermatitis were less likely to be evaluated by an allergist than white children. This research will be presented in full at the 2023 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI).

The atopic march typically begins early in life with atopic dermatitis (also known as "eczema"), and can eventually progress to the development of asthma, along with environmental and food allergies. "We already know that black children have higher rates of asthma," said Ellen D. Stephen, MD, first author of the study. "But the atopic march has just not been studied in black children as widely as it has in white children."

Researchers performed a retrospective chart review of children aged 0-18 years diagnosed with atopic dermatitis at a single center to determine if each patient was diagnosed with asthma, and if they were evaluated for asthma. Logistic regression was used to analyze the risk of asthma diagnosis and its association with race, sex, age, body mass index (BMI), insurance, and the Area Deprivation Index (ADI).

A total of 728 black children and 246 non-Hispanic white children with atopic dermatitis were identified. Among those in the study, 31.2% of black children were likely to have an asthma diagnosis, compared to 10% of white children. Analysis found that higher ADI, higher BMI, and greater age at time of evaluation were the factors most likely to impact the differences. Only 46.7% of black children were evaluated by an allergist, compared to 69% of white children. Black children were also significantly less likely to have undergone testing to environmental allergens.

"Asthma is a common, potentially life-threatening condition affecting the children in our country and allergist evaluation and environmental allergy testing can be essential to optimizing control of this disease," said Dr. Stephen. "To minimize existing healthcare disparities, more research must be done to help us understand what factors underlie the observed differences in the diagnosis and management of atopic diseases, so that we can overcome existing barriers to providing equitable asthma care".

Visit aaaai.org to learn more about atopic dermatitis and asthma. Research presented at the AAAAI Annual Meeting, February 24-27 in San Antonio, Texas, is published in an online supplement to The Journal of Allergy and Clinical Immunology.

The American Academy of Allergy, Asthma & Immunology (AAAAI) is the leading membership organization of more than 7,100 allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic and immunologic diseases. The AAAAI is the go-to resource for patients living with allergies, asthma and immune deficiency disorders. Established in 1943, the AAAAI has more than 7,100 members in the United States, Canada and 72 other countries. The AAAAI's Find an Allergist/Immunologist service is a trusted resource to help you find a specialist close to home.

Media Contact

April Presnell, The American Academy of Allergy, Asthma & Immunology, (414) 272-6071, [email protected]

 

SOURCE The American Academy of Allergy, Asthma & Immunology


These press releases may also interest you

at 02:00
QuTEM AB (formerly Vironova BioAnalytics AB), a leading provider of transmission electron microscopy (TEM) services, proudly announces the receipt of GMP (Good Manufacturing Practice) Certificates and Manufacturing Permits for Independent Quality...

at 01:54
FIRST QUARTER (JANUARY - MARCH 2024) Oder intake SEK 238.5 M (206.6)Net sales SEK 257.2 M (230.2)Operating profit SEK 45.8 M (23.7)Profit after tax SEK 36.7 M (17.6)Earnings per share before/after dilution SEK 1.07 (0.51)Cash flow SEK 87.9 M...

at 01:00
In response to valuable feedback from our customers, Luraco Technologies is thrilled to announce the launch of an upgrade to our medical massage chair lineup. We are introducing the Luraco i9 Max Plus Series, a revolution of the i9 Max Series. The i9...

at 00:01
Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients...

16 mai 2024
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...

16 mai 2024
Seelos Therapeutics, Inc. ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system ("CNS") disorders and rare diseases, announced today that it has entered into a...



News published on and distributed by: